ArticleDrug design, development and therapy2022

Design and Optimization of Rivaroxaban-Cyclodextrin-Polymer Triple Complex Formulation with Improved Solubility.

Ji-Hyun Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.